AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2004
Jul 19, 2004
35134_dirs_2004-07-19_77568b33-be83-4e73-b5f6-13c1efa0e2a2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CROFF ENTERPRISES INC (coff.ob)
CIK: 0000025743
Period of Report: 2004-07-16
Reporting Person: JENSEN GERALD L (Director, CEO/President, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2004-07-13 | Croff Enterprises, Inc. Common Stock | P | 500 | $1.89 | Acquired | 243488 | Direct |
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 16